HanchorBio Inc.
HanchorBio Inc., a leading biotechnology firm headquartered in Taiwan (TW), has been at the forefront of innovative solutions since its establishment. Specialising in advanced biopharmaceuticals and cutting-edge research, the company operates primarily in the Asia-Pacific region, with a growing presence in global markets. Founded in 2015, HanchorBio has achieved significant milestones, including the development of unique therapeutic products that address unmet medical needs. Their core offerings, which include monoclonal antibodies and biologics, are distinguished by their precision and efficacy, setting new standards in the industry. With a strong commitment to research and development, HanchorBio has positioned itself as a key player in the biopharmaceutical landscape, recognised for its contributions to healthcare advancements and patient outcomes.
DitchCarbon Score
How does HanchorBio Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
HanchorBio Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
HanchorBio Inc.'s reported carbon emissions
In 2022, HanchorBio Inc., headquartered in Taiwan (TW), reported no specific carbon emissions data, indicating a lack of disclosed emissions figures across all scopes (Scope 1, 2, and 3). This absence of data suggests that the company has not yet established a comprehensive emissions reporting framework or has not publicly disclosed its emissions. Furthermore, HanchorBio Inc. has not set any reduction targets or commitments, as evidenced by the lack of documented climate pledges or initiatives such as Science-Based Targets Initiative (SBTi) targets. This positions the company in a context where it may need to enhance its climate strategy to align with industry standards and expectations for transparency and accountability in carbon emissions management. As the company continues to develop its climate commitments, it may benefit from adopting industry best practices and engaging in initiatives that promote sustainability and emissions reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
HanchorBio Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
